| Application no. and date | 16821324.7 (espacenet) (Federated) (European Patent Register), 20160701 | | Patent/reg. no. and date | DK/EP 3318259, 20230111 | | Publication date | 20180509 | | Priority no. and date | JP 2015134817, 20150703 | | EP pub. no. and date |
EP 3318259 20180509 | | Effective date | | | Applicant/owner | Astellas Pharma Inc., 5-1, Nihonbashi-Honcho
2-chome
Chuo-ku
Tokyo 103-8411, JP | | Applicant ref. no. | P81784DK01 | | Inventor | MIYAZAKI, Masakazu, c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411, JP,
ISHIBA, Ryohei, c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411, JP,
TAKAISHI, Yuki, c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411, JP,
UEJO, Fumiaki, c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411, JP | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/497 (2006.01) , A61K 47/10 (2017.01) , A61K 47/26 (2006.01) , A61K 9/20 (2006.01) , A61P 35/00 (2006.01) | | Title | STABIL FARMACEUTISK SAMMENSÆTNING TIL ORAL INDGIVELSE | | Int. application no. | JP2016069615 | | Int. publication no. | WO2017006855 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
